Drug
AIV001
AIV001 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
completed375%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype
NCT04470726
completedphase_1
Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy
NCT04827875
completedphase_1
A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical Incision
NCT03639883
withdrawnphase_1
A Safety and Efficacy Study to Evaluate Rosacea
NCT03883945
Clinical Trials (4)
Showing 4 of 4 trials
NCT04470726Phase 1
Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype
NCT04827875Phase 1
Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy
NCT03639883Phase 1
A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical Incision
NCT03883945Phase 1
A Safety and Efficacy Study to Evaluate Rosacea
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4